CTI BioPharma Overview

CTI BioPharma Cost of Revenue

Cost of Revenue analysis for CTIC.

Quarterly Cost of Revenue

$1.22M

↑ 340.29% YoY

As of Mar 31, 2023

Annual Cost of Revenue (TTM)

$4.46M

↑ 1504.32% YoY

Trailing 12 months ending Mar 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin